PS

Panchatcharam Sharmila

Active Director Director DIN 10561241
DIN 10561241 First appointment Mar 2024 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Panchatcharam Sharmila

Data last updated:

Panchatcharam Sharmila is a Director at Clials Clinical Research Site Management Organisation Private Limited (since 2024). The company operates in Business Services.

DIN 10561241
Primary Designation Director
Industry Business Services
First Appointment 22 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Mar 20242024Active

Board colleagues of Panchatcharam Sharmila

Directorship timeline

Open interactive timeline →
Clials Clinical Research Site Management Organisation Private Limited
Premium access

Shareholding and investment profile for Panchatcharam Sharmila

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Panchatcharam Sharmila

Panchatcharam Sharmila currently holds 1 directorship: Clials Clinical Research Site Management Organisation Private Limited (Director, since 22 Mar 2024).

Panchatcharam Sharmila was first appointed on 22 Mar 2024 as Director at Clials Clinical Research Site Management Organisation Private Limited.

The current boards of Panchatcharam Sharmila's companies include Sivasankaran Venkatesan (Clials Clinical Research Site Management Organisation Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available